BEIJING PERCANS ONCOLOGY CO LTD has a total of 25 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ONK THERAPEUTICS LTD, BERMUDES DAVID GORDON and NANTCELL INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Chen Yiyou | 19 |
#2 | Zhang Yihong | 13 |
#3 | Yang Zhen | 10 |
#4 | Li Xiang | 6 |
#5 | Guo Dagang | 6 |
#6 | Liu Yang | 4 |
#7 | Wei Wang | 3 |
Publication | Filing date | Title |
---|---|---|
CA3109605A1 | Biomarkers for cancer therapy | |
EP3743438A2 | Cytokine fusion proteins | |
WO2020113403A1 | Cytokine fusion proteins | |
WO2020097901A1 | Biomarkers for cancer therapy | |
WO2020034061A1 | Biomarkers for cancer therapy | |
WO2019144309A1 | Cytokine Fusion Proteins | |
US2019284536A1 | Epithelial tumor cell cultures | |
WO2018218633A1 | Combination therapies for treating cancers | |
WO2018218485A1 | Epithelial tumor cell cultures | |
EP3426772A1 | Tumor cell suspension cultures and related methods | |
WO2018090375A1 | Epithelial tumor cell cultures |